Improving asthma control

GlaxoSmithKline announces extended asthma control therapy indication for children above a year of age.

GLAXOSMITHKLINE Pharmaceutical (GSK) recently announced an extended indication for fluticasone propionate 50mcg, a pressurised metered-dose inhaler which has a marked anti-inflammatory effect in the lungs.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Health , asthma , GlaxoSmithKline , child care , children's health , inhaler

Next In Health
Those 'educational' videos aren't helping your child speak
Reset your brain with a nap
How to eat healthily by the decade
Free school meals�provide modest benefits
When your kid has tooth troubles
He deals with dead people with a smile
Antiphospholipid syndrome: When your blood ‘sticks’ together
She collects maggots from dead people
Let us not forget these tropical diseases
Witnessing a forensic post-mortem first-hand

Trending in Lifestyle

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.